RE:RE:Bloom Burton drops TP to $0.80The Kinlytic sentence is the most important part of this update.
They will delve further into Kinlytic's value once the FDA meeting confirms the regulatory pathway.
As this has been confirmed with the FDA once (pre-covid) and it is a product that is sorely needed, competitor has a monopoly, we can reasonably hope for positive results.
IMO, that is the inflection point for the share price........Recognition of new milestones, reversal of prior write-downs, and a defined path to success.
Absent new QAPs deals I struggle to see a catalyst for a significant change in share price untlil then.